Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Fire Sale! What Pfizer’s Plan to Sell 40% of Itself Means in Practice
BNET Pharma
Monday, March 14, 2011 - 10:15pm
tags:
Pfizer
Glaxo drug for Parkinson’s disease works well in study
Bizjournals.com
Monday, March 14, 2011 - 10:13pm
tags:
Parkinson's Disease, IPX066, Impax, GSK
BioDelivery Sciences International: The Pieces Are Coming Together
Seeking Alpha
Monday, March 14, 2011 - 5:45pm
tags:
BioDelivery Sciences, Onsolis
Pfizer Shares Rise as Analyst Note Sparks Spin-Off Talk
WSJ Online
Monday, March 14, 2011 - 5:44pm
tags:
Pfizer, spin-offs
Medicare Illegally Paid for Seniors’ Viagra, U.S. Audit Says
Bloomberg
Monday, March 14, 2011 - 5:43pm
tags:
Medicare, Viagra, Pfizer
Court Rules Against Cephalon in Patent Case
Pharma Live
Monday, March 14, 2011 - 12:35pm
tags:
Cephalon, patents, Watson Pharmaceuticals, Fentora, painkillers
Eli's Lilly-putian Patent Cliff
Seeking Alpha
Monday, March 14, 2011 - 12:34pm
tags:
Eli Lilly, patents, Teva Pharmaceuticals, Pfizer, JNJ, Acrux, Abbott Laboratories
The J&J Consent Decree And CEO Bill Weldon
Pharmalot
Monday, March 14, 2011 - 11:45am
tags:
JNJ, consent decree, Pharma CEOs, William Weldon
Arena Pharmaceuticals: A Nail Biting Time for Lorcaserin Approval
Seeking Alpha
Monday, March 14, 2011 - 11:22am
tags:
Arena Pharmaceuticals, FDA, obesity
Pfizer May Begin To Unwind Years Of Mega-Mergers, Analyst Says
WSJ Online
Monday, March 14, 2011 - 11:21am
tags:
Pfizer, M&A
Legal challenges on branded drug patents way up
Fierce Pharma
Monday, March 14, 2011 - 11:15am
tags:
patents, generics
DUSA Pharmaceuticals: Small-Cap Biotech With a Healthy Cash Flow
Seeking Alpha
Monday, March 14, 2011 - 11:12am
tags:
DUSA pharmaceuticals, dermatology, Levulan photodynamic therapy, PDT
Who Will Win the Hepatitis C Market?
Seeking Alpha
Monday, March 14, 2011 - 10:44am
tags:
hepatitis C, Gilead Sciences, Merck, Bristol-Myers Squibb, Novartis, Pfizer, Vertex Pharmaceuticals, Pharmasset
Animal Health International, Inc. to merge with Lextron, Inc.
CP Wire
Monday, March 14, 2011 - 10:42am
tags:
animal health, Lextron, Animal Health International, M&A
Amgen Investors: ‘We Want A Dividend Already’
Pharmalot
Monday, March 14, 2011 - 10:21am
tags:
Amgen, dividends, investors
Dendreon's Golden Age Is Still in Its Infancy
Seeking Alpha
Monday, March 14, 2011 - 10:20am
tags:
Dendreon
Pozen's Success Will Depend on Execution of Unique Marketing Strategies
Seeking Alpha
Monday, March 14, 2011 - 10:19am
tags:
Pozen
Lilly Makes An ‘Irrevocable’ Offer to Acquire Janssen Business
Bloomberg
Monday, March 14, 2011 - 10:18am
tags:
Eli Lilly, animal health, Janssen Pharmaceuticals, JNJ, M&A
Gilead’s High Bar for AIDS Drugs Means New Development Withers
Bloomberg
Monday, March 14, 2011 - 10:16am
tags:
Gilead Sciences, AIDS, HIV, Merck, Bristol-Myers Squibb
Cadence Pharmaceuticals: A Rising Star
Seeking Alpha
Sunday, March 13, 2011 - 11:55am
tags:
Cadence Pharmaceuticals, Ofirmev, Bristol-Myers Squibb, pain management

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.